Sernova Receives Health Canada Approval to Initiate Human Clinical Trials of Its Cell Pouch(TM)
02 mai 2012 06h00 HE
|
Sernova Corp.
LONDON, ONTARIO--(Marketwire - May 2, 2012) - Sernova Corp. ("Sernova" or the "Company") (TSX VENTURE:SVA) today announced it received Health Canada Approval to conduct a human clinical...
Sernova Announces Appointments to Board of Directors
30 avr. 2012 06h03 HE
|
Sernova Corp
LONDON, ONTARIO--(Marketwire - April 30, 2012) - Sernova Corp. ("Sernova" or the "Company") (TSX VENTURE:SVA) today announced that at the annual general meeting held April 19, 2012, Bruce...
Sernova Receives Ethics Board Approval to Initiate First Clinical Study of Cell Pouch(TM)
19 avr. 2012 06h00 HE
|
Sernova Corp.
LONDON, ONTARIO--(Marketwire - April 19, 2012) - Sernova Corp. ("Sernova" or the "Company") (TSX VENTURE:SVA) today announced it has received the University of Alberta hospital ethics...
Sernova Completes $3.6M Non-Brokered Private Placement
03 avr. 2012 06h00 HE
|
Sernova Corp
LONDON, ONTARIO--(Marketwire - April 3, 2012) -
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Sernova...
Sernova Completes First Tranche of Non-Brokered Private Placement
29 févr. 2012 07h16 HE
|
Sernova Corp.
LONDON, ONTARIO--(Marketwire - Feb. 29, 2012) -
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Sernova...
Sernova Announces $3.5 Million Private Placement
16 févr. 2012 11h14 HE
|
Sernova Corp.
LONDON, ONTARIO--(Marketwire - Feb. 16, 2012) -
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Sernova...
Sernova Receives Patent Allowance in Japan
19 janv. 2012 06h00 HE
|
Sernova Corp.
LONDON, ONTARIO--(Marketwire - Jan. 19, 2012) - Sernova Corp. (TSX VENTURE:SVA), today announced that the Japan Patent Office has issued a Notice of Allowance to Sernova for a patent...
Sernova to Present Company and Clinical Update at Biotech Showcase(TM) San Francisco
09 janv. 2012 06h00 HE
|
Sernova Corp.
LONDON, ONTARIO--(Marketwire - Jan. 9, 2012) - Sernova Corp. (TSX VENTURE:SVA), today announced that Dr. Philip Toleikis, Ph.D., President and CEO of Sernova, will present an update on...
Sernova Provides Summary of 2011 Accomplishments and Corporate Update for 2012
23 déc. 2011 06h00 HE
|
Sernova Corp
LONDON, ONTARIO--(Marketwire - Dec. 23, 2011) - Sernova Corp. (TSX VENTURE:SVA), is pleased to provide a synopsis of accomplishments for 2011 including an update on clinical development...
Sernova Retains Investor Relations Firm Russo Partners LLC
17 nov. 2011 06h00 HE
|
Sernova Corp
LONDON, ONTARIO--(Marketwire - November 17, 2011) - Sernova Corp. (TSX VENTURE:SVA), is pleased to announce that it has retained Russo Partners LLC, a leading healthcare communications...